Pharmaceutical combination and its use for treating synucleinopathies

• 收藏
• 分享

专利权人:

Chase Therapeutics Corporation

发明人:

Chase, Thomas N.,Clarence-Smith, Kathleen E.

申请号：

AU2018250628

公开号：

AU2018250628A1

申请日:

2018.04.11

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present invention describes the combination of a 6-propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine or of a pharmaceutically acceptable salt or solvate thereof with fluoxetine or a pharmaceutically acceptable salt or solvate thereof, for use for treating a synucleinopathy such as Parkinson's disease, Lewy body disease, mutations in the glucocerebrosidase gene, or multiple system atrophy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/